BiomX (NYSEAMERICAN:PHGE) Shares Scheduled to Reverse Split on Tuesday, November 25th

Shares of BiomX Inc. (NYSEAMERICAN:PHGE) are going to reverse split on Tuesday, November 25th. The 1-19 reverse split was announced on Friday, November 14th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, November 24th.

BiomX Trading Down 15.9%

BiomX stock traded down $0.06 during mid-day trading on Monday, hitting $0.32. The stock had a trading volume of 1,263,897 shares, compared to its average volume of 1,705,503. BiomX has a one year low of $0.31 and a one year high of $1.16. The firm has a market capitalization of $9.18 million, a P/E ratio of -0.24 and a beta of 1.46. The firm’s 50 day moving average is $0.51 and its 200 day moving average is $0.50.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $15.00 price objective on shares of BiomX in a research note on Wednesday, August 20th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $15.00.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).